Maria Ferrantini

3.1k citations

47 papers · 2.5k indexed · h-index 27

Impact in

Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune Response and Inflammation
- interferon and immune responses
Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers

Papers in

Immunology 35
- Immunotherapy and Immune Responses 29
- T-cell and B-cell Immunology 14
- Immune Cell Function and Interaction 13
Oncology 21
- CAR-T cell therapy research 6
- Cancer Immunotherapy and Biomarkers 5
- Viral-associated cancers and disorders 5

Co-authors: Filippo Belardelli Giulio C. Spagnoli Michael Heberer Elisabetta Padovan Imerio Capone Enrico Proietti John M. Kirkwood Stefano M. Santini
Journals: The Journal of Immunology (4 papers)American Journal Of Pathology (3 papers)International Journal of Cancer (3 papers)Gene Therapy (3 papers)Clinical & Experimental Metastasis (3 papers)
Partner nations: Italy France United States

In The Last Decade

Maria Ferrantini

47 papers receiving 2.4k citations

Peers

Countries citing papers authored by Maria Ferrantini

Since Specialization

Citations

This map shows the geographic impact of Maria Ferrantini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Ferrantini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Ferrantini more than expected).

Fields of papers citing papers by Maria Ferrantini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Ferrantini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Ferrantini. The network helps show where Maria Ferrantini may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Maria Ferrantini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maria Ferrantini Line = papers co-authored together Maria Ferrantini links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells Cancer Immunology Research ·Luciano Castiello, Paola Sestili, Giovanna Schiavoni, Rosanna Dattilo, S. Estrada, Fiorella Ciaffoni, Manuela Iezzi, Alessia Lamolinara, Antonella Sistigu, Federica Moschella, Abdulrahman Ali Bedaiwy, Daniele Macchia, Maria Ferrantini, Ann Zeuner, Mauro Biffoni, Enrico Proietti, Filippo Belardelli, Eleonora Aricò	2018	35
2	MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68 Vaccine ·Eleonora Aricò, S. Estrada, Giuseppina D’Agostino, Federica Moschella, Massimo Venditti, Ulrich Kalinke, Deborah Allen, Anthony A. Nash, Filippo Belardelli, Maria Ferrantini	2011	6
3	Interferon-α-Conditioned Human Monocytes Combine a Th1-Orienting Attitude with the Induction of Autologous Th17 Responses: Role of IL-23 and IL-12 PLoS ONE ·Stefano M. Santini, Caterina Lapenta, Simona Donati, Francesca Spadaro, Filippo Belardelli, Maria Ferrantini	2011	57
4	Opposing Effects of Toll-like Receptor (TLR3) Signaling in Tumors Can Be Therapeutically Uncoupled to Optimize the Anticancer Efficacy of TLR3 Ligands Cancer Research ·Rosa Conforti, Yuting Ma, Yannis Morel, Carine Paturel, Magali Terme, Sophie Viaud, Bernard Ryffel, Maria Ferrantini, Ravindra Uppaluri, Robert D. Schreiber, Christophe Combadière, Nathalie Chaput, Fabrice André, Guido Kroemer, Laurence Zitvogel	2010	87
5	IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity Immunobiology ·Laura Lattanzi, Carmela Rozera, Diego Marescotti, Giuseppina D’Agostino, Laura Santodonato, Famara Vidaurre Gutiérrez, Filippo Belardelli, Riccardo Gavioli, Maria Ferrantini	2010	38
6	The Critical Role of IL-15 in the Antitumor Effects Mediated by the Combination Therapy Imatinib and IL-2 The Journal of Immunology ·Grégoire Mignot, Evelyn Ullrich, Mathieu Bonmort, Cédric Menard, Lionel Apétoh, Julien Taı̈eb, Daniela Bosisio, Silvano Sozzani, Maria Ferrantini, Enerson Cruziniani, Matthias Mack, Richard Kantelberg, Silvia Bulfone‐Paus, Laurence Zitvogel, Nathalie Chaput	2008	39
7	IFN-alpha in the Generation of Dendritic Cells for Cancer Immunotherapy Handbook of experimental pharmacology ·Stefano M. Santini, Caterina Lapenta, Laura Santodonato, Giuseppina D’Agostino, Filippo Belardelli, Maria Ferrantini	2008	49
8	Dendritic cells and cytokines in immune rejection of cancer Cytokine & Growth Factor Reviews ·Maria Ferrantini, Imerio Capone, Filippo Belardelli	2007	47
9	Exosomes as Potent Cell-Free Peptide-Based Vaccine. II. Exosomes in CpG Adjuvants Efficiently Prime Naive Tc1 Lymphocytes Leading to Tumor Rejection The Journal of Immunology ·Nathalie Chaput, Noël E.C. Schartz, Fabrice André, Julien Taı̈eb, Sophie Novault, 一彦山下, Kharisul Wathoni, Jacky Bernard, François A. Lemonnier, Miriam Mérad, Gosse J. Adema, Malcolm Adams, Maria Ferrantini, Alain Carpentier, Bernard Escudier, Thomas Tursz, Eric Angevin, Laurence Zitvogel	2004	224
10	Monocyte-Derived Dendritic Cells Generated After a Short-Term Culture with IFN-α and Granulocyte-Macrophage Colony-Stimulating Factor Stimulate a Potent Epstein-Barr Virus-Specific CD8+ T Cell Response The Journal of Immunology ·Laura Santodonato, Giuseppina D’Agostino, Roberto Nisini, Sabrina Mariotti, S. Estrada, Massimo Spada, Laura Lattanzi, Maria Paola Perrone, Mauro Andreotti, Filippo Belardelli, Maria Ferrantini	2003	63
11	Humoral Immune Response and Protection from Viral Infection in Mice Vaccinated with Inactivated MHV-68: Effects of Type I Interferon Journal of Interferon & Cytokine Research ·Eleonora Aricò, Kevin A. Robertson, Deborah Allen, Maria Ferrantini, Filippo Belardelli, Anthony A. Nash	2002	9
12	Interferon-alpha in tumor immunity and immunotherapy Cytokine & Growth Factor Reviews ·Filippo Belardelli, Maria Ferrantini, Enrico Proietti, John M. Kirkwood	2002	263
13	Antitumor activity of recombinant adenoviral vectors expressing murine IFN-α in mice injected with metastatic IFN-resistant tumor cells Cancer Gene Therapy ·Laura Santodonato, Maria Ferrantini, Fabio Palombo, Luigi Aurisicchio, Paola Delmastro, Al-Baldawi Maryam Firas, Stefania Di Marco, Gennaro Ciliberto, Mark Du, Milton W. Taylor, Filippo Belardelli	2001	22
14	Inhibition of Angiogenesis and Vascular Tumor Growth by Interferon-Producing Cells American Journal Of Pathology ·Adriana Albini, Maria Schütz, Priscilla Campiolo Manesco Paixão, Roberto Benelli, Luciana Masiello, Carlo Tacchetti, Marı́a Rosa Bono, Maria Ferrantini, Carmela Rozera, Mauro Truini, Filippo Belardelli, Leonardo Santi, Douglas M. Noonan	2000	106
15	Conference on cancer vaccines Cancer Immunology Immunotherapy ·Dirk Schadendorf, Filippo Belardelli, Maria Ferrantini, Dimitry Severyukhin, Mario P. Colombo	2000	2
16	Interferon (IFN)-β Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN-α American Journal Of Pathology ·Carmela Rozera, Davide Carlei, Pier‐Luigi Lollini, Carla De Giovanni, Piero Musiani, Emma Di Carlo, Filippo Belardelli, Maria Ferrantini	1999	38
17	Cure of Mice with Established Metastatic Friend Leukemia Cell Tumors by a Combined Therapy with Tumor Cells Expressing Both Interferon- α 1 and Herpes Simplex Thymidine Kinase Followed by Ganciclovir Human Gene Therapy ·Laura Santodonato, Maria Ferrantini, Lucia Gabriele, Enrico Proietti, Massimo Venditti, Piero Musiani, Andrea Modesti, Judith Lorenz, Stephen D. Lupton, Filippo Belardelli	1996	34
18	IFN‐α₁ gene transfection completely abolishes the tumorigenicity of murine B16 melanoma cells in allogeneic DBA/2 mice and decreases their tumorigenicity in syngeneic C57BL/6 mice International Journal of Cancer ·Thomas Kaido, Marie‐Thérèse Bandu, Chantal Maury, Maria Ferrantini, Filippo Belardelli, Ion Gresser	1995	41
19	Studies on the expression of H-2 antigens in non-metastatic and highly metastatic Friend erythroleukemia cells: correlation with thein vivo behaviour of tumor cells Clinical & Experimental Metastasis ·Maria Ferrantini, Simonetta Pulciani, Enrico Proietti, G Lespinats, Anna Maria Anastasi, V. Ciolli, Paola Rizza, Filippo Belardelli	1989	1
20	Wheat germ agglutinin-binding protein changes in highly malignant Friend leukemia cells metastasizing to the liver Clinical & Experimental Metastasis ·Giuliano Elia, Maria Ferrantini, Filippo Belardelli, Enrico Proietti, Ion Gresser, Carla Amici, A. Benedetto	1988	9

About Maria Ferrantini

Maria Ferrantini is a scholar working on Immunology, Oncology, Immunology and Allergy, Genetics and Biotechnology, having authored 47 papers that have together received 2.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (29 papers), T-cell and B-cell Immunology (14 papers), Immune Cell Function and Interaction (13 papers), Virus-based gene therapy research (10 papers), CAR-T cell therapy research (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Viral-associated cancers and disorders (5 papers) and Cytomegalovirus and herpesvirus research (5 papers). The work is most often cited by research in Immunology (1.7k citations), Oncology (902 citations), Virology (82 citations), Cancer Research (216 citations) and Biotechnology (106 citations). Maria Ferrantini has collaborated with scholars based in Italy, France and United States. Frequent co-authors include Filippo Belardelli, Giulio C. Spagnoli, Michael Heberer, Elisabetta Padovan, Imerio Capone, Enrico Proietti, John M. Kirkwood, Stefano M. Santini, Laura Santodonato and Caterina Lapenta. Their work appears in journals such as The Journal of Immunology, American Journal Of Pathology, International Journal of Cancer, Gene Therapy and Clinical & Experimental Metastasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact